MedTrace Logo

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

NCT00951795 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-07-21

No results posted yet for this study

Summary

This is a multi-center study designed to assess the accuracy of Pima™ CD4 Test to enumerate CD4+ T-cells in whole blood over the measurement range expected for the intended population. The Pima CD4 Test consists of the Pima™ CD4 cartridge and Pima™ Analyzer to identify and determine the absolute counts of mature helper (CD3+/CD4+) T-lymphocytes in whole blood.

Conditions

  • HIV Infection
  • AIDS
  • HIV Infections

Sponsors & Collaborators

  • Inverness Medical Innovations

    collaborator INDUSTRY

  • Abbott RDx Cardiometabolic

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00951795 on ClinicalTrials.gov